In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination
Whitehead, Stephen S ; Durbin, Anna P ; Pierce, Kristen K ; Elwood, Dan ; McElvany, Benjamin D ; Fraser, Ellen A ; Carmolli, Marya P ; Tibery, Cecilia M ; Hynes, Noreen A ; Jo, Matthew ; Lovchik, Janece M ; Larsson, Catherine J ; Doty, Elena A ; Dickson, Dorothy M ; Luke, Catherine J ; Subbarao, Kanta ; Diehl, Sean A ; Kirkpatrick, Beth D Messer, William B
PLoS neglected tropical diseases, 2017-05, Vol.11 (5), p.e0005584-e0005584 [Periódico revisado por pares]United States: Public Library of Science
Texto completo disponível